Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of a global pandemic. Safe and effective COVID-19 vaccines are now available, including mRNA-1273, which has shown 94% efficacy in prevention of symptomatic COVID-19 disease. However, the emergence of SARS-CoV-2 vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Kai, Choi, Angela, Koch, Matthew, Elbashir, Sayda, Ma, LingZhi, Lee, Diana, Woods, Angela, Henry, Carole, Palandjian, Charis, Hill, Anna, Jani, Hardik, Quinones, Julian, Nunna, Naveen, O'Connell, Sarah, McDermott, Adrian B., Falcone, Samantha, Narayanan, Elisabeth, Colpitts, Tonya, Bennett, Hamilton, Corbett, Kizzmekia S., Seder, Robert, Graham, Barney S., Stewart-Jones, Guillaume B.E., Carfi, Andrea, Edwards, Darin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572694/
https://www.ncbi.nlm.nih.gov/pubmed/34815117
http://dx.doi.org/10.1016/j.vaccine.2021.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572694/
https://www.ncbi.nlm.nih.gov/pubmed/34815117
http://dx.doi.org/10.1016/j.vaccine.2021.11.001

Ejemplares similares